NasdaqCM:BLFSLife Sciences
How Investors Are Reacting To BioLife Solutions (BLFS) Return To Profitability And Reaffirmed 2026 Outlook
In early May 2026, BioLife Solutions reported first‑quarter 2026 results showing revenue of US$27.5 million versus US$22.05 million a year earlier, with net income improving to US$1.19 million from a net loss of US$0.448 million and earnings per share rising to US$0.02.
The company also reiterated its 2026 outlook, pointing to ongoing demand for its biopreservation media franchise, mid‑60% gross margin expectations, and a shift to full‑year GAAP profitability supported by a cash balance of...